Oral ketamine vs placebo in patients with cancer-related neuropathic pain
Ketamine hydrochloride is used as an adjuvant treatment for cancer-related neuropathic pain, but evidence of its effectiveness is limited.1 Findings of a large trial investigating the use of ketamine for general cancer pain were negative, but the population studied did not specifically have neuropat...
Full description
Bibliographic Details
| Main Authors: |
Fallon, Marie T.,
Wilcock, Andrew,
Kelly, Caroline A.,
Paul, James,
Lewsley, Liz-Anne,
Norrie, John,
Laird, Barry J. A. |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
American Medical Association
2018
|
|---|
| Online Access: | https://eprints.nottingham.ac.uk/51161/
|
|---|